SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Brain metastases at SNO 2026

Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website

27 organizations at SNO 2026 present work in brain and leptomeningeal metastases: 18 hospitals and cancer centers, 7 universities and institutes and 2 drug developers. Between them they bring 322 presentations to the program. Most represented: MD Anderson Cancer Center, Mass General Brigham and University of Michigan. As of Nov 12, 2026.

All 419 organizations at SNO 2026 →

Format
Top represented
Showing 1–1 of 27 organizations
OrganizationSNO 2026 Attendance
Hospitals & cancer centers
A cancer center providing patient care and conducting cancer research, including neuro-oncology.
Talk
Wed Nov 11
8:30–10:40am
Primer on Neuropathology
Terrace Ballroom I Convention Center
Talk
Wed Nov 11
10:55am–1pm
Session
Thu Nov 12
12:30–3:30pm
SNO Executive Leadership Workshop - By Application Only
122 AB, First Floor, Convention Center
Session
Thu Nov 12
4:30–5:35pm
Session
Fri Nov 13
10:15–11:15am
Session
Fri Nov 13
10:15–11:15am
Neurosurgery Oral Abstracts Session I
119 AB, First Floor, Convention Center
Neurosurgery
Talk
Fri Nov 13
10:22–10:29am
Talk
Fri Nov 13
11:54–11:57am
Talk
Fri Nov 13
12:03–12:06pm
Paired spatial transcriptomics reveals recurrence-associated remodeling of malignant and myeloid niches in glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract CNSC-11
Neuroscience
Talk
Fri Nov 13
12:27–12:30pm
Talk
Fri Nov 13
2:30–2:37pm
Session
Fri Nov 13
5–6pm
CNS Metastases Oral Abstracts Session I
120 ABC, First Floor, Convention Center
Metastases
Talk
Fri Nov 13
5:44–5:49pm
Poster
Fri Nov 13
7:30–9:30pm
Refining glioma risk through subtype-specific effects of susceptibility variants
Exhibit Hall D & E, Second Floor, Convention Center · Abstract BIOM-02
Biomarkers
Poster
Fri Nov 13
7:30–9:30pm
Molecular Profiles of Long-Term Survivors with Unmethylated MGMT Glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract BIOM-40
Biomarkers
Poster
Fri Nov 13
7:30–9:30pm
An investigation of molecular factors influencing outcomes among Grade 4 IDH mutant astrocytoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract BIOM-69
Biomarkers
Poster
Fri Nov 13
7:30–9:30pm
Cortical thinning of Precuneus links to behavioral difficulties in children with NF1 and delayed brain aging
Exhibit Hall D & E, Second Floor, Convention Center · Abstract CNSC-12
Neuroscience
Poster
Fri Nov 13
7:30–9:30pm
An image-informed mechanistic model to predict brain metastases growth and therapy response
Exhibit Hall D & E, Second Floor, Convention Center · Abstract CNSC-47
Neuroscience
Poster
Fri Nov 13
7:30–9:30pm
Cortical brain aging reveals treatment- and sex-dependent effects in melanoma patients
Exhibit Hall D & E, Second Floor, Convention Center · Abstract CNSC-50
Neuroscience
Poster
Fri Nov 13
7:30–9:30pm
Elevated MAPK pathway alteration load in long-term survivors of glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract CSIG-05
Tumor biology
Poster
Fri Nov 13
7:30–9:30pm
Targeting of P300/CBP Amplifies and Sustains Delta‑24‑RGD Induced Antitumor Response in Pediatric Diffuse Midline Gliomas
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-24
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
Exploiting Tumor Stress and Innate Immunity: ONC201 Enhances NK Cell Therapy for Pediatric Diffuse Midline Gliomas
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-26
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
Role of HSP90 inhibition in modulating the glioblastoma tumor microenvironment.
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-35
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
FLASH radiation reprograms tumor associated myeloid cells and spares circulating antigen-reactive CD8+ T-cells in mouse glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-54
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
Noninvasive Mapping of Tumor Cell Size Distribution Using Deep Learning and Susceptibility-Contrast MRI
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMG-30
Neuroimaging
Poster
Fri Nov 13
7:30–9:30pm
2-HG MRS and Neurocognitive Function Monitoring During Vorasidenib Treatment in IDH-Mutant Gliomas: An All-Comers Pilot Study
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMG-62
Neuroimaging
Poster
Fri Nov 13
7:30–9:30pm
Mirdametinib and Other MEK Inhibitors in NF1-Associated High-Grade Glioma: Outcomes From a Single-Institution Cohort and Literature Review
Exhibit Hall D & E, Second Floor, Convention Center · Abstract NCOG-06
Survivorship
Poster
Fri Nov 13
7:30–9:30pm
Enhancing Tumor Volume Outperforms BT-RADS for Prediction of Radiographic Progression-Free Survival in Glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract NCOG-25
Survivorship
Poster
Fri Nov 13
7:30–9:30pm
Executive function and processing speed impact behavioral pattern separation in older adults with glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract NCOG-38
Survivorship
Poster
Fri Nov 13
7:30–9:30pm
Electrocorticography–Direct Electrical Stimulation Concordance and Tract-Based Outcome Associations During Awake Language Mapping
Exhibit Hall D & E, Second Floor, Convention Center · Abstract NCOG-41
Survivorship
Poster
Fri Nov 13
7:30–9:30pm
Tracking longitudinal post-operative changes in motor representations using navigated Transcranial Magnetic Stimulation: a pilot study
Exhibit Hall D & E, Second Floor, Convention Center · Abstract NCOG-42
Survivorship
Poster
Fri Nov 13
7:30–9:30pm
Clinical and molecular features of synchronous and metachronous primary brain tumors
Exhibit Hall D & E, Second Floor, Convention Center · Abstract PATH-68
Pathology
Poster
Fri Nov 13
7:30–9:30pm
Extracranial Metastasis in Pediatric Supratentorial H3K27-Altered Diffuse Midline Glioma Following Ventriculoperitoneal Shunt Placement
Exhibit Hall D & E, Second Floor, Convention Center · Abstract QOL-25
Survivorship
Poster
Fri Nov 13
7:30–9:30pm
Adjuvant chemotherapy is associated with improved outcomes after laser interstitial thermal therapy in glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract SURG-08
Neurosurgery
Poster
Fri Nov 13
7:30–9:30pm
Tumor treating fields (TTFields) promote permeabilization of brain microvascular endothelial cell membranes and impair neovascular formation
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMIC-52
Tumor biology
Poster
Fri Nov 13
7:30–9:30pm
A Replication-Permissive Hamster Model of Mesenchymal GBM Reveals Oncolytic Virus-Driven Immune Triads and Microenvironmental Reprogramming
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMIC-85
Tumor biology
Poster
Fri Nov 13
7:30–9:30pm
Functional in vivo CRISPR knockout screen identifies metabolic vulnerabilities within melanoma brain metastasis
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMOD-18
Therapeutics
Talk
Sat Nov 14
10:36–10:43am
Survival in virotherapy-treated gliomas correlates with T cell receptor diversity and immune organization
118 ABC, First Floor, Convention Center · Abstract IMMU-16
Immunology · Tumor biology
Talk
Sat Nov 14
11:33–11:36am
Talk
Sat Nov 14
12:03–12:06pm
Adjuvant Systemic Therapy Use in Newly Diagnosed and Transformed WHO Grade 3 Meningioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract NCOG-46
Survivorship
Talk
Sat Nov 14
12:12–12:15pm
Session
Sat Nov 14
5–6pm
CNS Rare Tumor Oral Abstracts Session II
119 AB, First Floor, Convention Center
Rare tumors
Session
Sat Nov 14
5–6pm
Endovascular Surgical Neuro-Oncology: An Evolving Field
Terrace Ballroom IV Convention Center
Neurosurgery
Talk
Sat Nov 14
5:21–5:28pm
Talk
Sun Nov 15
11:34–11:39am
The role of tumor suppressors in neuron-glial crosstalk during gliomagenesis
119 AB, First Floor, Convention Center · Abstract CNSC-08
Neuroscience

Explore the full SNO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full SNO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in brain and leptomeningeal metastases

Tell us what you sell and we’ll find the people at organizations working on brain and leptomeningeal metastases most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse SNO 2026 by

Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction